# Vitamin C Blood Pressure Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/vitamin-c-blood-pressure-meta-analysis-evidence-review
Category: evidence-review
Summary: Vitamin C Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are 
Last reviewed: 2026-08-05
Reviewed by: Migaku Evidence Review
# Vitamin C Blood Pressure Meta-analysis: What the Evidence Says

## Quick Answer

Vitamin C Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Effect of vitamin D supplementation on blood lipids in patients with metabolic syndrome: a meta-analysis | systematic review | 1 | 2026-04-13 | 10.7717/peerj.21086 |
| Triglyceride-glucose-based indices in relation to vitamin D concentrations among adults with metabolic syndrome | preclinical study | 4 | 2026-06-01 | 10.1371/journal.pone.0349683 |

## What The Sources Report

- In modern societies, widespread vitamin D deficiency has emerged as a critical global health concern, attributable to reduced outdoor activities and application of extensive skin coverage. [Wang Qijun (2026); evidence level 1]
- However, emerging evidence has revealed its pleiotropic effects extending far beyond skeletal health. [Wang Qijun (2026); evidence level 1]
- Metabolic syndrome (MetS) is a cluster of conditions comprising hypertension, hyperglycemia, central obesity, and dyslipidemia, which are considered risk factors for the future development of type 2 diabetes mellitus (T2DM), cardiovascular disease (CVD), and certain cancers. [Rana Raju (2026); evidence level 4]
- Paradoxically, despite abundant sunlight, factors such as increased urbanization, reduced outdoor activities, and darker skin pigmentation aid in widespread VDD in the Indian community. [Rana Raju (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For vitamin c blood pressure meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Wang Qijun (2026). Effect of vitamin D supplementation on blood lipids in patients with metabolic syndrome: a meta-analysis. DOI: 10.7717/peerj.21086. PMCID: PMC13086024. PMID: 42004716. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13086024/
- Rana Raju (2026). Triglyceride-glucose-based indices in relation to vitamin D concentrations among adults with metabolic syndrome. DOI: 10.1371/journal.pone.0349683. PMCID: PMC13225404. PMID: 42224164. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13225404/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.